Take Solutions Ltd Quality Grade Downgrade Highlights Fundamental Challenges

Overview of Quality Grade Change and Market Context

Take Solutions Ltd’s Mojo Score currently stands at 33.0, accompanied by a Sell rating, marking a cautious stance for investors. The downgrade in quality grade signals a notable decline in the company’s fundamental strength relative to its peers in the Healthcare Services sector. The stock price closed at ₹27.98 on 22 May 2026, up 4.99% on the day, but remains significantly below its 52-week high of ₹49.90, reflecting volatility and underlying challenges.

Comparatively, the stock’s returns have been mixed over various time horizons. While it delivered a robust 175.12% return over the past year, it has underperformed the Sensex benchmark over the 1-month (-42.77% vs. -5.16%), year-to-date (-29.63% vs. -11.78%), 5-year (-58.30% vs. +48.76%), and 10-year (-80.91% vs. +197.15%) periods. This inconsistency underscores the company’s struggle to sustain growth momentum amid sectoral and macroeconomic pressures.

Declining Sales Growth and Profitability Trends

One of the most glaring weaknesses is the company’s five-year sales growth, which has contracted sharply by 41.25%. This negative trajectory contrasts with a modest improvement in EBIT growth, which increased by 14.75% over the same period. The divergence suggests that while operational earnings have shown some resilience, top-line pressures remain a significant concern.

Profitability ratios further highlight the company’s challenges. The average Return on Capital Employed (ROCE) stands at a low 3.89%, indicating suboptimal utilisation of capital resources. Similarly, the average Return on Equity (ROE) is a mere 1.79%, reflecting limited value creation for shareholders. These figures are considerably below sector averages, signalling inefficiencies in generating returns from invested capital.

Leverage and Interest Coverage Concerns

Financial leverage metrics reveal a mixed picture. The average Debt to EBITDA ratio is 1.45, which is moderate but not alarming. However, the average Net Debt to Equity ratio of 0.27 indicates some reliance on debt financing, albeit at manageable levels. More concerning is the average EBIT to Interest ratio of -3.65, which is negative and suggests that earnings before interest and tax are insufficient to cover interest expenses, raising red flags about the company’s ability to service debt comfortably.

These leverage indicators, combined with weak profitability, contribute to the downgrade in quality grade, as they imply heightened financial risk and potential liquidity constraints if operational performance does not improve.

Operational Efficiency and Capital Utilisation

Take Solutions’ average Sales to Capital Employed ratio is 1.13, which suggests that the company generates just over a rupee of sales for every rupee of capital employed. While this is not particularly low, it does not indicate strong capital efficiency either, especially when paired with the low ROCE and ROE figures. The lack of tax expense (0.00% tax ratio) and absence of dividend payout data further complicate the assessment of the company’s cash flow management and shareholder returns.

Institutional holding remains minimal at 29%, and there are no pledged shares, which may indicate limited external investor confidence and a lack of insider financial distress signals. However, the low institutional interest could also reflect scepticism about the company’s growth prospects and quality of earnings.

Peer Comparison and Sector Positioning

Within the Healthcare Services sector, Take Solutions is rated below average in quality compared to peers such as Dynacons Systems, Silver Touch, Expleo Solutions, and InfoBeans Technologies, all of which hold average quality grades. This relative underperformance highlights the company’s struggle to keep pace with sector standards in operational and financial metrics.

The downgrade from a non-qualifying status to below average quality grade is a clear signal that the company’s fundamentals have deteriorated, warranting caution from investors and analysts alike.

Investment Implications and Outlook

Investors considering Take Solutions Ltd should weigh the company’s recent share price gains against its deteriorating fundamental quality. The downgrade to a below average quality grade, combined with weak sales growth, low returns on capital, and negative interest coverage, suggests that the company faces significant operational and financial headwinds.

While the stock’s strong one-year return of 175.12% may attract momentum investors, the longer-term underperformance relative to the Sensex and peers indicates underlying structural issues. The micro-cap status of the company also implies higher volatility and risk, which may not suit conservative portfolios.

Given these factors, a cautious approach is advisable, with close monitoring of upcoming quarterly results and any strategic initiatives aimed at improving profitability and capital efficiency.

Summary of Key Financial Metrics

To recap, the critical financial parameters for Take Solutions Ltd are:

• Five-year Sales Growth: -41.25%
• Five-year EBIT Growth: +14.75%
• Average EBIT to Interest Coverage: -3.65 (negative)
• Average Debt to EBITDA: 1.45
• Average Net Debt to Equity: 0.27
• Average Sales to Capital Employed: 1.13
• Average ROCE: 3.89%
• Average ROE: 1.79%
• Institutional Holding: 29%
• Pledged Shares: 0%

These figures collectively underpin the downgrade in quality grade and the Sell rating assigned by MarketsMOJO.

Conclusion

Take Solutions Ltd’s recent quality grade downgrade to below average reflects a clear deterioration in its business fundamentals. The company’s declining sales, weak returns on capital, and negative interest coverage ratio highlight operational inefficiencies and financial stress. While the stock has shown sporadic price strength, the fundamental challenges suggest that investors should exercise caution and consider alternative opportunities within the Healthcare Services sector or broader market.

Continuous monitoring of the company’s financial performance and strategic direction will be essential to reassess its investment potential in the coming quarters.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →